SCHEMBL7172176

SCHEMBL7172176

COc1cc2c(c(OC)c1C)CCCC2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 1/20 0.49
BRD4 O60885 2/20 0.47
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B1 P14061 1/20 0.39
HSD17B3 P37058 1/20 0.39
BRAF P15056 1/20 0.38
TUBB4A P04350 2/20 0.37
TUBB P07437 2/20 0.37
TUBA3C P0DPH7 2/20 0.37
TUBA1B P68363 2/20 0.37
TUBA4A P68366 2/20 0.37
TUBB4B P68371 2/20 0.37
TUBB3 Q13509 2/20 0.37
TUBB2A Q13885 2/20 0.37
TUBB8 Q3ZCM7 2/20 0.37
TUBA3E Q6PEY2 2/20 0.37
TUBA1A Q71U36 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11708730 0.90 BRD4 (0.46) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL4121479 0.87 KDM4E (0.51) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL4132763 0.83 KDM4E (0.51) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL4123012 0.83 KDM4E (0.51) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL7998453 0.80 KDM4E (0.54) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL6113256 0.79 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL11957286 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL611321 0.77 ALDH1A1 (0.81) ALDH1A1KDM4EHPGDBRD4MAPT
SCHEMBL6113045 0.76 KDM4E (0.64) ALDH1A1KDM4EHPGDMAPTTUBB4A
SCHEMBL11708180 0.75 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDBRD4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941112-B1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS VERTEX PHARMA (US) 2003-02-12 EP disclosed
EP-0839143-B1 TETRALIN COMPOUNDS WITH MDR ACTIVITY VERTEX PHARMA (US) 2002-08-07 EP disclosed
US-5811434-A ADMINISTERING A COMPOSITION COMPRISING A NEUROTROPHIC AMOUNT OF A COMPOUND AND A NEUROTROPHIC FACTOR, SUCH AS NERVE GROWTH FACTOR VERTEX PHARMACUETICALS INCORPORATED (US) 1998-09-22 US disclosed
US-5726184-A TREATMENT OF MULTI-DRUG RESISTANT CELLS TO RESTORE SENSITIVITY TO THERAPEUTIC OR PROPHYLACTIC AGENTS VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-03-10 US disclosed